Research.Patient.info
Transthyretin Amyloid Cardiomyopathy (ATTR CM) research hub
2 indexed studies · 2 currently recruiting
- recruitingPHASE3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
This study looks at a new medicine called Coramitug for heart failure caused by a condition called ATTR amyloidosis. It aims to see if Coramitug can reduce serious heart problems. People will either get the medicine or a dummy treatment, alongside their usual care.
United States · Argentina · Australia - not yet recruitingPHASE2
A Study to Evaluate the Efficacy and Safety of Concomitant Use of Eplontersen and ALXN2220 Compared With Eplontersen and Placebo for Adults Participants With ATTR-CM.
This study is testing two medicines, eplontersen and ALXN2220, to see if they are safe and help adults with a heart condition called ATTR-CM. Participants will take eplontersen along with either ALXN2220 or an inactive substance (placebo).
United States · Canada · China